Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
F 8.36 -1.99% -0.17
JNCE closed down 1.99 percent on Wednesday, May 5, 2021, on 45 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical JNCE trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Earnings Movers Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Fell Below 200 DMA Bearish -1.99%
Earnings Movers Other -1.99%
Down 3 Days in a Row Weakness -1.99%
Down 4 Days in a Row Weakness -1.99%
Older End-of-Day Signals for JNCE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band about 5 hours ago
Down 2 % about 6 hours ago
Lower Bollinger Band Support about 6 hours ago
Down 1% about 8 hours ago
200 DMA Resistance about 9 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibody Monoclonal Antibodies

Is JNCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.79
52 Week Low 4.3
Average Volume 413,930
200-Day Moving Average 8.57
50-Day Moving Average 10.51
20-Day Moving Average 9.30
10-Day Moving Average 9.28
Average True Range 0.64
ADX 11.0
+DI 18.24
-DI 28.69
Chandelier Exit (Long, 3 ATRs ) 8.93
Chandelier Exit (Short, 3 ATRs ) 10.12
Upper Bollinger Band 10.35
Lower Bollinger Band 8.25
Percent B (%b) 0.05
BandWidth 22.64
MACD Line -0.40
MACD Signal Line -0.39
MACD Histogram -0.0143
Fundamentals Value
Market Cap 333.16 Million
Num Shares 39.9 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 13.31
Price-to-Sales 2.24
Price-to-Book 2.58
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.19
Resistance 3 (R3) 9.25 9.03 9.05
Resistance 2 (R2) 9.03 8.82 9.00 9.00
Resistance 1 (R1) 8.70 8.69 8.59 8.64 8.96
Pivot Point 8.48 8.48 8.43 8.45 8.48
Support 1 (S1) 8.15 8.27 8.04 8.09 7.76
Support 2 (S2) 7.93 8.14 7.90 7.72
Support 3 (S3) 7.60 7.93 7.67
Support 4 (S4) 7.54